Background: Arf GAPs are multidomain proteins that function in membrane traffic by inactivating the GTP binding protein Arf1. Numerous Arf GAPs contain a BAR domain, a protein structural element that contributes to membrane traffic by either inducing or sensing membrane curvature. We have examined the role of a putative BAR domain in the function of the Arf GAP ASAP1. Results: ASAP1's N terminus, containing the putative BAR domain together with a PH domain, dimerized to form an extended structure that bound to large unilamellar vesicles containing acidic phospholipids, properties that define a BAR domain. A recombinant protein containing the BAR domain of ASAP1, together with the PH and Arf GAP domains, efficiently bent the surface of large unilamellar vesicles, resulting in the formation of tubular structures. This activity was regulated by Arf1GTP binding to the Arf GAP domain. In vivo, the tubular structures induced by ASAP1 mutants contained epidermal growth factor receptor (EGFR) and Rab11, and ASAP1 colocalized in tubular structures with EGFR during recycling of receptor. Expression of ASAP1 accelerated EGFR trafficking and slowed cell spreading. An ASAP1 mutant lacking the BAR domain had no effect. Conclusions: The N-terminal BAR domain of ASAP1 mediates membrane bending and is necessary for ASAP1 function. The Arf dependence of the bending activity is consistent with ASAP1 functioning as an Arf effector.
Introduction
The controlled bending of membranes is crucial to fundamental cellular processes including membrane traffic. The transfer of materials between organelles depends on physical changes that occur in the membranes and are mediated, in part, by vesicle-coat proteins such as COPI, COPII, and clathrin [1] [2] [3] . Coat proteins adsorb to a donor membrane and then polymerize. Coincident with polymerization, the membrane deforms into a bud and vesiculates into a transport intermediate. Coat proteins must be shed for vesicles to be delivered to an acceptor compartment.
Many coat proteins are controlled by ADP-ribosylation factor 1 (Arf1), a member of the Arf family of GTP binding proteins [4] [5] [6] [7] . Arf1GTP both tightly associates with membranes and binds to coat proteins, consequently recruiting coat proteins to membranes. After vesicle formation is complete, hydrolysis of GTP to generate Arf1GDP is necessary for coat-protein release from the membrane. Because Arfs have no detectable GTPase activity, GTPase-activating proteins (GAPs) are necessary for Arf1 function [6] .
The Arf GAPs form a family of proteins that induce hydrolysis of GTP bound to Arf [8] . The first Arf GAP identified was Arf GAP1, which has a catalytic domain composed of a zinc-finger motif. Subsequently, 24 genes have been found to encode an Arf GAP domain. Seventeen of these genes can be divided into six subgroups that encode proteins with demonstrated Arf GAP activity: Arf GAP1/2/3; Git1/2; ASAP1/2/3; ACAP1/2/3; ARAP1/2/3, and AGAP1/2/3. The latter four subgroups are called the AZAPs; all have a catalytic core of pleckstrin homology (PH), Arf GAP, and ankyrin (ANK) repeat domains.
AZAP-family Arf GAPs have been found to contain BAR domains [9] . BAR domains, first recognized in the mammalian proteins Bin and amphiphysin [10, 11] and in the yeast proteins Rvs167 and Rvs161 [12] , dimerize to form a banana-shaped structure that binds to acid phospholipids, induces or detects membrane curvature, and binds to other proteins [9, 13] . In one Arf GAP (ACAP1), the BAR domain occurs immediately N-terminal to a PH domain [9] . Given the importance of controlled membrane bending to the formation of membrane-transport intermediates, the BAR domains found in AZAP family Arf GAPs have been proposed to have a role in AZAP function in membrane trafficking.
ASAP1 is an AZAP-family Arf GAP that affects focaladhesion dynamics [14] and endosomal trafficking [15] . Sequence analysis indicates that the amino terminal 310 amino acids may contain a BAR domain [9] . Here, we have found they indeed have physical and biochemical properties consistent with the presence of a BAR domain. Our results have led us to propose that the BAR domain mediates an Arf effector function of ASAP1 that contributes to the formation of transport intermediates.
Results

ASAP1 Has a BAR Domain
Analysis of the primary sequence of ASAP1 ( Figure 1A ) and computer modeling indicated that residues 46-267 could form a BAR domain, a bundle of three a helices that homodimerize in an extended crescent-shaped structure (see Figure 1B) . A largely positive electrostatic potential distinguishes this structure from other BAR domains. As described in the Supplemental Data available online, we determined that within residues 35 to 314, there was a region of the protein with the physical properties of a BAR domain and that a protein containing both the BAR and PH domains of ASAP1 ([1-431]ASAP1, designated BAR-PH throughout this paper, Figure 1 ) was a dimer that could sense membrane curvature and induce limited deformation of large unilamellar vesicles (LUVs).
The BAR Domain Does Not Confer Curvature Dependence on GAP Activity of ASAP1 Our results established that a protein comprising the BAR and PH domains of ASAP1 (BAR-PH) could sense membrane curvature as determined by binding to LUVs of different sizes. This led us to test the idea that the BAR domain of ASAP1 renders the GAP activity sensitive to membrane curvature. We compared the activities of two recombinant proteins. One protein, ASAP1, contained the BAR, PH, Arf GAP, and ANK repeat domains (abbreviated here as BAR-PZA, see Figure 1C ). The second protein, [325-724]ASAP1, lacked the BAR domain and consisted of the PH, Arf GAP, and ANK repeat domains (abbreviated as PZA). LUVs of defined size were prepared by extrusion through membranes with controlled pore sizes. The GAPs were titrated into the reaction to determine relative catalytic efficiency (Figure 2 ). When examined with LUVs of a phospholipid The following abbreviations are used: BAR denotes Bin, amphiphysin, and RVS167 and 161; PH denotes pleckstrin homology; Arf GAP denotes ADP-ribosylation-factor-directed GTPase-activating protein; A denotes ankyrin repeat; and SH3 denotes Src-homology 3 domain.
composition that was optimal for GAP activity (+PS, LUVs containing 40% phosphatidylcholine, 25% phosphatidylethanolamine, 15% phosphatidylserine, 10% cholesterol, 9.5% phosphatidylinositol, and 0.5% phophatidylinositol 4,5-bisphosphate), LUV size did not affect the activity of either BAR-PZA or PZA (Figures 2A  and 2B ). We also tested the size dependence of GAP activity in LUVs of a composition that was less than optimal for activity (2PS, LUVs containing 55% phosphatidylcholine, 25% phosphatidylethanolamine, 10% cholesterol, 9.5% phosphatidylinositol, and 0.5% phosphatidylinositol 4,5-bisphosphate), reasoning that the effect of size might be more evident with lower basal GAP activity. Even with 2PS LUVs, GAP activity of BAR-PZA was independent of vesicle size ( Figure 2C ).
The BAR Domain Is Regulated by the Arf GAP Domain We next considered whether the Arf GAP domain could affect function of the BAR domain. As an initial test, we determined whether the Arf GAP domain influenced the lipid binding properties of the BAR-PH domains. Binding of BAR-PZA and PZA to +PS and 2PS LUVs prepared by extrusion through filters with 1.0 and 0.1 mm pores was measured ( Figure 3A) . BAR-PZA bound to LUVs to a greater extent than did PZA. The two proteins, however, were similar in other ways. Binding of both BAR-PZA and PZA was dependent on acid phospholipids and was independent of LUV size. We considered that Arf binding to ASAP1 might restore the dependence on LUV size that had been observed with BAR-PH; however, the presence of 10 mM myristoylated Arf1GppNHp in the incubations did not influence the binding of BAR-PZA to the LUVs (not shown).
We also examined whether the Arf GAP domain and Arf1GTP binding to the Arf GAP domain affected BAR-domain-induced deformation of membranes. When incubated with 2PS LUVs, BAR-PZA by itself did not affect the shape of LUVs but did induce tubulation if Arf1, bound to the nonhydrolyzable GTP analog GppNHp, was present. Arf1GDP did not induce tubulation with BAR-PZA, and Arf1GppNHp did not induce tubulation in the absence of BAR-PZA (not shown). When incubuated with +PS LUVs, BAR-PZA by itself induced tubulation ( Figure 3B ). The tubules observed were approximately 20 nm in diameter, consistent with the dimensions observed for the amphiphysin BAR domain [9] . The BAR domain was necessary for tubulation because PZA did not induce deformation of the LUV surface, even in the presence of Arf1GppNHp with +PS LUVs ( Figure 3B ).
The BAR Domain Affects Membrane Structure In Vivo
Our in vitro results were consistent with the BAR domain of ASAP1 regulating membrane structure. We next determined whether ASAP1 tubulated membranes in vivo. NIH 3T3 fibroblasts expressing BAR, PH, and BAR-PH were examined by immunofluorescence ( Figure 4 ). Although all three proteins expressed to similar levels (not shown) and were found associated with some tubules, BAR-PH most efficiently induced tubular structures ( Figures 4A and 4B ). The GAP domain affected in vivo function of the BAR-PH domains. BAR-PZA did not induce membrane tubulation to the same extent as BAR-PH when expressed in NIH 3T3 fibroblasts. However, tubules containing ASAP1 and Arf were observed in over 50% of the cells when treated with tetrafluoroaluminate (AlF 4 ), which can stabilize the complex of GTP binding proteins with their cognate Arf GAPs [16] (arrows in Figures 4D c and  4D d , BAR-PZA detected through FLAG; Figure 4E ). Similar results were obtained using full-length ASAP1 (Figures 4D k and 4D l ) . The effect of AlF 4 was dependent on its ability to stabilize a complex of Arf1 and ASAP1.
[R497K]BAR-PZA lacks the putative catalytic arginine finger in the Arf GAP domain and therefore is defective in binding Arf1GDPAlF 4 Tubular-vesicular intermediates have been found to be involved in recycling [17, 18] , which led us to consider a potential involvement of ASAP1 containing tubules in growth factor receptor trafficking. As a first test, we determined whether ASAP1 colocalized with EGFR in similar structures during EGFR recycling. HeLa cells expressing EGFR fused to enhanced green fluorescent protein (EGFP-EGFR) and epitope-tagged ASAP1 or [DBAR]ASAP1 were treated for 30 min with EGF and then transferred to EGF-free media. After an additional 20 min incubation, the cells were fixed and EGFR and ASAP1 were visualized. Tubular structures containing EGFR were observed under these conditions ( Figure 5 ). Full-length ASAP1 colocalized with EGFR in these structures ( Figure 5B ).
[DBAR]ASAP1 did not ( Figure 5C ). These results were consistent with that BAR domain being necessary for ectopically expressed ASAP1 incorporating into a structure that may depend on endogenous ASAP1 to form.
The BAR Domain Affects In Vivo Function of ASAP1
The potential role of the BAR domain of ASAP1 on EGFR recycling was further examined by determining the effect of ASAP1 and [DBAR]ASAP1 on levels of internalized fluorescent EGF after a pulse of uptake in HeLa cells. Cells were incubated for 30 min with Alexa488 EGF at 4ºC and then transferred to media lacking growth factors at 37ºC. The amount of cell-associated fluorescent EGF was determined for 5 to 60 min. At 5 and 10 min, no difference between nontransfected cells and cells expressing ASAP1 or [DBAR]ASAP1 was detected (Figure 6 ), indicating that uptake was not affected. Example micrographs for a 10 min chase are shown for cells expressing ASAP1 in Figures 6A a-d and for [DBAR]ASAP1 in Figures  6B a-d . However, after a chase of 30 min or more, the cellassociated fluorescence in cells expressing ASAP1 decreased relative to nontransfected cells and cells The BAR domain was also necessary for effects of ASAP1 on the cytoskeleton (see Supplemental Data). Expression of recombinant ASAP1 truncation mutants containing the BAR domain affected the rate of cell spreading. Truncation mutants lacking the BAR domain had no effect.
Discussion
We have examined the function of the BAR domain in ASAP1. We found that a protein containing the BAR and GAP domains of ASAP1 caused the tubulation of LUVs and that the activity was dependent on Arf1GTP and lipid composition of the LUV. We also examined the role of the BAR domain for in vivo ASAP1 function and found that a membranous tubular compartment containing EGFR was induced by ASAP1 mutants, depending on the presence of the BAR domain. ASAP1 associated with a tubular compartment containing EGFR during receptor recycling. Furthermore, ASAP1 affected EGFR trafficking and cell spreading, depending on the BAR domain. We conclude that the BAR domain of ASAP1 mediates physical changes of the membranes of endocytic organelles critical for ASAP1 cellular function.
BAR domains either induce or detect membrane curvature. Having established that ASAP1 does have a BAR domain, we determined which role it had. Curvature sensitivity has been observed with Arf GAP1; however, ASAP1 has a number of differences from Arf GAP1 [8, 19] , which likely explain the differences in the interaction of the two GAPs with LUVs. In our experiments with LUVs prepared in the same way and of the same composition as used for Arf GAP1, GAP activity was not dependent on LUV size. On further investigation, we found that ASAP1 efficiently deformed membranes, manifested as tubules. The tubulating activity was dependent on the phospholipid composition of the LUVs and Arf1GTP. Our in vivo results, examining the mutants [R360Q]BAR-PZA and [R497K]BAR-PZA, are also consistent with a role for both Arf1GTP and phospholipids binding for the tubulating activity. We propose that similar to other proteins such as WASP [20, 21] , ASAP1 could detect the coincidence of the two signals with a response of membrane deformation. Other Arf GAPs with BAR domains may have a similar ArfGTP-dependent tubulating activity to the one we have previously observed in vivo tubulation of membranes on activation of Arf6 with AlF 4 in cells overexpressing the Arf6 GAP ACAP1 [22] .
The Arf1GTP-dependent effect on membrane bending has led us to consider new models for the function of Arf GAPs in membrane traffic. We propose that, in addition to inactivating Arf, ASAP1 may have an active role in generating transport intermediates from an endocytic compartment, which can be vesicular or tubular in nature [23] . Arf1GTP directly contributes by binding to the Arf GAP domain and indirectly by regulating the production of acidic phospholipids through activation of phospholipase D, phosphatidylinositol kinase, and phosphatidylinositol phosphate 5-kinase [24] [25] [26] [27] . The synergistic binding of phosphoinositides and Arf1GTP to ASAP1 drives membrane bending (Figure 7) . Thus, overexpression of ASAP1 could lead to accelerated recycling of EGFR [15] . This function of an Arf GAP also fits well with recent work in which Arf GAP1 and ACAP1 have been considered to be integral participants in forming transport vesicles [28] [29] [30] . Arf GAPs have also been found to bind to coat proteins [31] [32] [33] [34] [35] . On the basis of these characteristics, we propose that Arf GAPs could function as a subunit of coat proteins, like the Sar1 GAP Sec23, which is a subunit of COPII, a coat involved in ER-to-Golgi trafficking [36] . We are also exploring the possibility that some Arf GAPs, such as ASAP1, could form novel vesicle coats not associated with conventionally recognized coat proteins. Their multiple domains could allow for cargo binding, as has been recently described for the family member ACAP1 [30] , in addition to the membrane bending function.
The PH domain that lies between the Arf GAP and BAR domains could function as a controlled relay. We have found that the PH domain of ASAP1 folds with the GAP domain [37] . Conformational changes in the PH domain consequent to phosphoinositide binding affect GAP activity. Our preliminary analysis indicates that the PH domain may also fold with the BAR domain. Mutation of a residue resulting in reduced phosphoinositide binding affected both Arf GAP activity and tubulation activity. These relationships have two possible consequences. First, ArfGTP binding to the GAP domain could induce conformational changes relayed through the PH domain to affect BAR function. Second, BARdomain changes that result from interacting with a membrane could be transmitted to the Arf GAP through the PH domain and provide a means of regulating GAP activity such that it occurs after membrane bending. Thus, ASAP1 could function both as an Arf effector and an Arf GAP.
Conclusions
The N terminus of ASAP1 was found to contain a BAR domain that is necessary for ASAP1-dependent regulation of cell spreading and EGFR recycling. A protein composed of the BAR, PH, and Arf GAP domains, under control of phospholipids and Arf1GTP, induced membrane-delimited tubules. The data presented in this paper support the hypothesis that ASAP1 is an Arf effector with activity mediated by the BAR domain.
Experimental Procedures Plasmids
Mammalian expression vectors for epitope-tagged ASAP1b (accession number AAC98350) and ASAP1 deletion mutants, with the exception of FLAG-tagged [325-724]ASAP1 (PZA for PH, zinc finger, and ANK repeat: the Arf GAP domain is composed of a zinc finger), are described elsewhere [38, 39] . FLAG-tagged PZA was constructed in pCI (Promega, Madison, Wisconsin) with standard molecular-biology procedures. The mammalian expression vector for HA-tagged wild-type Arf1 was a generous gift from Julie Donaldson (National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland). In the proposed model, Arf1GTP binds ASAP1 and activates phosphatidylinositol kinases generating polyphosphoinositides that bind to the PH and BAR domains of ASAP1, synergistically driving the formation of a curved surface. purification of myristoylated Arf1 has been described [40] . Arf1 was also prepared with a system modified by using an expression vector for Arf1, generously provided by Geraint Thomas (University College, London; personal communication), that could be induced independently of N-myristoyltransferase expression. pEYFP-MEM was from BD Biosciences (Palo Alto, California).
Antibodies
Polyclonal and monoclonal (clone M5) antibodies recognizing the FLAG epitope were from Sigma (Saint Louis, Missouri). A monoclonal antibody to EGFR was obtained from Santa Cruz Biotechnology (Santa Cruz, California). A rabbit polyclonal antibody and mouse monoclonal antibody (clone HA.11) recognizing the HA epitope were purchased from Covance (Berkeley, California). A monoclonal antibody recognizing the Myc epitope was from Upstate Biotechnology (Lake Placid, New York). Alexa 488-or Alexa 594-conjugated goat anti-mouse or goat anti-rabbit secondary antibodies were from Molecular Probes (Eugene, Oregon). Arf was detected with mouse anti-Arf (clone 1D9) (Affinity Bioreagents, Golden, Colorado). ASAP1 was detected with rabbit polyclonal anti-ASAP1 antibody [14] .
Other Proteins [325-724]ASAP1 (PZA) was expressed and purified from bacteria as described [39] . Other ASAP1-derived proteins with His 6 tags were expressed in bacteria. The bacteria were lysed in 20 mM Tris, 100 mM NaCl containing a protease-inhibitor cocktail (Complete, Roche Applied Science, Indianapolis, Indiana). The lysate was fractionated on a His Trap column (Amersham Biosciences, Piscataway, New Jersey) in an imidazole, pH 7.0, gradient of 10 to 300 mM in 500 mM NaCl. The proteins were exchanged into a phosphate buffer by adsorbing to hydroxylapatite and eluting with 500 mM KPi, pH 7.0. Myristoylated Arf was expressed in bacteria and purified as described [40] .
Electron Microscopy
For negatively stained images, a carbon-coated EM grid was placed on a 10 ml sample drop for 2 min, blotted with filter paper, chemically stained with 2% uranyl acetate for 2 min, blotted again, and air dried. Negatively stained specimens were examined in a transmission electron microscope, Philips CM120 (FEI), operated at 100 kV. Images were recorded digitally on a 794 Gatan MultiScan CCD camera with the DigitalMicrograph software package [41] .
Immunofluorescence Cells were seeded overnight in 12-well plates containing fibronectincoated (25 mg/ml) coverslips and then transfected with 1 mg DNA/ well for 18-20 hr by using FuGENE 6 (Roche Diagnostics, Indianapolis, Indiana). For cotransfections, plasmid DNA was used at a 1:1 ratio. Where indicated, cells in DMEM with 0.5% BSA were treated for 30 min with tetrafluoraluminate formed by addition of NaF to 30 mM followed by the addition of AlCl 3 to 50 mM. Cells were fixed and stained as described [14] . Internalization of Alexa488-EGF was performed as described [42] . In brief, HeLa cells were incubated with Alexa488 EGF (2 mg/ml, obtained from Molecular Probes) at 4ºC for 30 min. Cells were then washed twice and incubated in serumfree medium from 5 min to 1 hr as indicated. For quantitation, tubules were defined as intracellular structures that were at least five times longer than their width. Cells were scored positive for tubule formation if they contained two or more EYFP-MEM-positive tubule structures. Three independent experiments were conducted with a minimum of 50 transfected cells counted per experiment.
Immunoprecipitation and Immunoblotting NIH 3T3 fibroblasts grown on 100 mm plates were transfected by using FuGENE-6 (Roche) with a total of 12 mg of plasmids directing expression of the indicated proteins. After 18 hr, the cells were harvested into lysis buffer containing 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM MgCl 2 , 1% Triton X-100, 100 mM ATP, and one mini Complete EDTA-free protease-inhibitor tablet (Roche) per 10 ml buffer, lysed for 30 min and centrifuged at 10,000 3 g at 4ºC for 10 min. The cleared lysates were immunoprecipitated with anti-FLAG beads (Sigma). The pellets were washed three times with lysis buffer. Precipitated proteins were separated by SDS-PAGE and transferred to nitrocellulose. Proteins were detected by immunoblotting using enhanced chemiluminescence (ECL) (Amersham Biosciences).
Miscellaneous GAP activity was determined as described [39] with LUVs prepared by extrusion and myristoylated Arf1 as a substrate. Protein binding to sucrose-loaded LUVs was determined as described [39] . Protein concentrations were estimated with the BioRad reagent (BioRad, Hercules, California). SAA cells were a generous gift from Ivan Dikic (Frankfurt University, School of Medicine). NIH 3T3 fibroblasts were a generous gift from Douglas Lowy (National Cancer Institute, NIH, Bethesda, Maryland). A model of the BAR domain of ASAP1 was constructed on the basis of the crystal structural model of the BAR domain of endophilin as described in Supplemental Data.
Supplemental Data
Supplemental Data include Supplemental Results and Discussion, Supplemental Experimental Procedures (including a description of the preparation of lipid large unilamellar vesicles), and six figures and are available with this article online at: http://www.currentbiology.com/cgi/content/full/16/2/130/DC1/.
